GlassScriptPhysician profile
Patricia M Mueller
NPI 1144260373
$29,753.07
in general payments reported to CMS, 2019-2025
54 companies · $5,670 in 2025
The $5,670 reported for 2025 was more than what 87% of Rheumatology providers received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,823 · 2020: $2,425 · 2021: $3,543 · 2022: $4,554 · 2023: $4,878 · 2024: $4,859 · 2025: $5,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15K · Education: $16.68.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15,390.65 |
| Education | $16.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $4,623.27 | 2019-2025 | Enbrel, Tavneos, Krystexxa |
| Abbvie INC. | $3,295.10 | 2019-2025 | |
| Janssen Biotech, INC. | $2,828.25 | 2019-2025 | Tremfya, Stelara |
| Ucb, INC. | $2,626.87 | 2019-2025 | Cimzia, Bimzelx |
| Novartis Pharmaceuticals Corporation | $1,956.07 | 2019-2025 | |
| Mallinckrodt Hospital Products INC. | $1,500.67 | 2020-2025 | Acthar |
| Aurinia Pharma U.S., INC. | $1,249.45 | 2021-2025 | Lupkynis |
| Lilly USA, LLC | $1,209.78 | 2019-2024 | Taltz |
| Pfizer INC. | $1,129.36 | 2019-2025 | |
| Radius Health, INC. | $1,084.96 | 2019-2025 | Tymlos |
| Glaxosmithkline, LLC. | $1,075.93 | 2019-2025 | Benlysta |
| Ani Pharmaceuticals, INC. | $766.38 | 2022-2025 | Purified Cortrophin Gel, Sovuna |
| E.R. Squibb & Sons, L.L.C. | $608.19 | 2019-2025 | Orencia |
| Astrazeneca Pharmaceuticals LP | $558.02 | 2021-2025 | Saphnelo, Evusheld |
| Horizon Therapeutics Plc | $545.60 | 2019-2023 | Krystexxa |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Mueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.